Elly Gerald Stoica

Array ( [id] => 10208402 [patent_doc_number] => 20150093391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-02 [patent_title] => 'ONCOSTATIN M (OSM) ANTAGONISTS FOR PREVENTING CANCER METASTASIS AND IL-6 RELATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 14/478175 [patent_app_country] => US [patent_app_date] => 2014-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 25787 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14478175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10822082 [patent_doc_number] => 20160168246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-16 [patent_title] => 'Method For Treating Tumors That Possess The CCK-C Receptor With The 3B9.1 Monoclonal Antibody' [patent_app_type] => utility [patent_app_number] => 14/474284 [patent_app_country] => US [patent_app_date] => 2014-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5725 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14474284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12543162 [patent_doc_number] => 10010588 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-03 [patent_title] => Methods of using pegylated interleukin-10 for treating hyperlipidemia [patent_app_type] => utility [patent_app_number] => 14/908992 [patent_app_country] => US [patent_app_date] => 2014-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 17 [patent_no_of_words] => 30015 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14908992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10255011 [patent_doc_number] => 20150140009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-21 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF RADIATION EXPOSURE' [patent_app_type] => utility [patent_app_number] => 14/463324 [patent_app_country] => US [patent_app_date] => 2014-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 82 [patent_figures_cnt] => 82 [patent_no_of_words] => 67581 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14463324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10997448 [patent_doc_number] => 20160194394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-07 [patent_title] => 'ANTIBODIES AGAINST FRIZZLED PROTEINS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/911983 [patent_app_country] => US [patent_app_date] => 2014-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 29230 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14911983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10621680 [patent_doc_number] => 09340617 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-17 [patent_title] => 'Targeted/immunomodulatory fusion proteins and methods for making same' [patent_app_type] => utility [patent_app_number] => 14/458674 [patent_app_country] => US [patent_app_date] => 2014-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 65 [patent_figures_cnt] => 65 [patent_no_of_words] => 13927 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14458674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10938905 [patent_doc_number] => 20140341926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-20 [patent_title] => 'METHOD FOR EGFR DIRECTED COMBINATION TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 14/450342 [patent_app_country] => US [patent_app_date] => 2014-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9420 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14450342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11075753 [patent_doc_number] => 20160272717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-22 [patent_title] => 'ANTI-GARP PROTEIN AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/908368 [patent_app_country] => US [patent_app_date] => 2014-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 33018 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14908368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9895074 [patent_doc_number] => 20150050273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-19 [patent_title] => 'AFUCOSYLATED ANTI-FGFR2IIIB ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 14/447751 [patent_app_country] => US [patent_app_date] => 2014-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 25237 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14447751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12193885 [patent_doc_number] => 09897608 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-20 [patent_title] => 'Detection of ovarian cancer using antibody arrays' [patent_app_type] => utility [patent_app_number] => 14/915395 [patent_app_country] => US [patent_app_date] => 2014-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7843 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14915395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12212149 [patent_doc_number] => 09908944 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-06 [patent_title] => 'Antibodies that bind urokinase plasminogen activator' [patent_app_type] => utility [patent_app_number] => 14/905409 [patent_app_country] => US [patent_app_date] => 2014-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 32581 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14905409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10628733 [patent_doc_number] => 09346878 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-24 [patent_title] => 'Methods of treating glomerulonephritis associated with IGA nephropathy for TACI-immunoglobulin fusion proteins' [patent_app_type] => utility [patent_app_number] => 14/331567 [patent_app_country] => US [patent_app_date] => 2014-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 30218 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14331567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10149028 [patent_doc_number] => 09181303 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-10 [patent_title] => 'Treatment of bacterial infections with cyclic antimicrobial peptides' [patent_app_type] => utility [patent_app_number] => 14/311093 [patent_app_country] => US [patent_app_date] => 2014-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9789 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14311093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10267163 [patent_doc_number] => 20150152160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-04 [patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES' [patent_app_type] => utility [patent_app_number] => 14/300724 [patent_app_country] => US [patent_app_date] => 2014-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60191 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14300724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10240910 [patent_doc_number] => 20150125905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-07 [patent_title] => 'CELL CULTURE IMPROVEMENTS' [patent_app_type] => utility [patent_app_number] => 14/294821 [patent_app_country] => US [patent_app_date] => 2014-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 47161 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14294821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10939967 [patent_doc_number] => 20140342987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-20 [patent_title] => 'USE OF IXOLARIS, A TISSUE FACTOR INHIBITOR, FOR THE TREATMENT AND PREVENTION OF CANCER' [patent_app_type] => utility [patent_app_number] => 14/292232 [patent_app_country] => US [patent_app_date] => 2014-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21833 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14292232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10789967 [patent_doc_number] => 20160136123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-19 [patent_title] => 'TREATMENT OF AUTOPHAGY-RELATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 14/898062 [patent_app_country] => US [patent_app_date] => 2014-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 27498 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14898062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14593985 [patent_doc_number] => 10350167 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-07-16 [patent_title] => Targeted delivery of drugs to the myometrium via anti-oxytocin receptor antibodies [patent_app_type] => utility [patent_app_number] => 14/892927 [patent_app_country] => US [patent_app_date] => 2014-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6951 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14892927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11907084 [patent_doc_number] => 09775881 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-03 [patent_title] => 'Methods of treating mesothelioma by administration of compounds comprising FGFR1 ECD' [patent_app_type] => utility [patent_app_number] => 14/890047 [patent_app_country] => US [patent_app_date] => 2014-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 32923 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14890047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9805234 [patent_doc_number] => 20150017179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-15 [patent_title] => 'Method of Treatment and Bioassay Involving Macrophage Migration Inhibitory Factor (MIF) as Cardiac-Derived Myocardial Depressant Factor' [patent_app_type] => utility [patent_app_number] => 14/281870 [patent_app_country] => US [patent_app_date] => 2014-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 38829 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14281870 [rel_patent_id] =>[rel_patent_doc_number] =>)